Key issues in the diagnosis and management of tuberculosis

Journal of the Royal Society of Medicine

Volumn 100, Issue 3, 2007, Pages 134-141

  Milburn, Heather ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; GAMMA INTERFERON; INFLIXIMAB; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

CHEMOPROPHYLAXIS; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMORBIDITY; DATA BASE; GENETIC SUSCEPTIBILITY; HUMAN; INCIDENCE; MONOTHERAPY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PARASITOSIS; PATHOGENESIS; REVIEW; RISK ASSESSMENT; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; TOXIC HEPATITIS; TUBERCULIN TEST; TUBERCULOSIS; VITAMIN D DEFICIENCY;

EID: 34147103865     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.100.3.134     Document Type: Review

References (45)

1. Fox W. The Modern Management and Therapy of Pulmonary Tuberculosis. Proc Roy Soc Med 1977;70:4-15
2. Zink AR, Grabner W, Nerlich AG. Molecular identification of human tuberculosis in recent and historic bone tissue samples: The role of molecular techniques for the study of historic tuberculosis. Am J Phy Anthropol 2005;126:32-47
3. Bunyan J. In: Brown, J, ed. The Life and Death of Mr Badman. Cambridge: Cambridge University Press, 1905
4. Myers JA. Captain of All These Men of Death. Tuberculosis Historical Highlights. St Louis: Warren H Green, 1977
5. Bodington G. An Essay on the Treatment and Cure of Pulmonary Consumption. London: Sinopkin, Marshall, Hamilton and Kent, 1840
6. Koch R. "Die Aetiologie und die Bekampfung der Tuberkulose", lecture delivered to the Physiological Society of Berlin, 24 March 1882 (trans. W. de Rouville). Med Classics 1938;2:853-80
7. Ryan F. Tuberculosis: The Greatest Story Never Told. Yorkshire: Swift, 1992
8. World Health Organization. WHO Global Tuberculosis Programme: Global TB Control. Geneva: WHO, 1998:237
9. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991;72:1-6
10. Chiba Y, Kurihara T. Development of pulmonary tuberculosis with special reference to the time interval after tuberculin conversion. Bull Int Union Tuberc 1979;54:263-4
11. NICE Guidelines. Tuberculosis. Clinical Diagnosis and Management of Tuberculosis, and Measures For Its Prevention and Control. London: Royal College of Physicians of London, 2006
12. Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 1990;322:422-7
13. Talbot EA, Moore M, McCray E, Binkin NJ. Tuberculosis among foreign-born persons in the United States, 1993-1998. JAMA 2000;284:2894-900
14. Hoge CW, Fisher L, Donnell HD Jr, et al. Risk factors for transmission of Mycobacterium tuberculosis in a primary school outbreak: lack of racial difference in susceptibility to infection. Am J Epidemiol 1994;139:520-30
15. Bentwich Z, Kalinkovitch A, Weisman Z, Borkow G, Beyers N, Beyers AD. Can eradication of helminth infections change the face of AIDS and tuberculosis? Immunol Today 1999;20:485-7
16. Savioli L, Stansfield S, Bundy DA, et al. Schistosomiasis and soil-transmitted helminth infections: forging control efforts. Trans R Soc Trop Med Hyg 2002;96:577-9
17. Beyers AD, vanRie A, Adams J, Fenhalls G, Gie RP, Beyers N. Signals that regulate the host response to M. tuberculosis. Novartis Foundation Symposium, 1998;217:145-57
18. Stadecker MJ, Hernandez HJ. The immune response and immunopathology in infection with Schistosoma mansonii: a key role of major egg antigen Sm-p40. Parasite Immunol 1998:20:217-21
19. Pearce EJ, Caspar P, Grzych JM, Lewis FA, Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansonii. J Expl Med 1991;173:159-66
20. Orme IM, Roberts AD, Griffin JP, et al. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993;151:518-25
21. Baliko Z, Szereday L, Szekeres-Bartho J. Th2 biased immune responses in cases with active Mycobacterium tuberculosis infection and tuberculin allergy. FEMS Immunol Med Microbiol 1998;22:199-204
22. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996;335:1941-9
23. Davies PD, Brown RC, Woodhead JS. Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax 1985;40:187-90
24. Ustianowski A, Shaffer R, Collin S, Wilkinson RJ, Davidson RN. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect 2005;50:432-7
25. Rook GAW. The role of vitamin D in tuberculosis. Am Rev Respir Dis 1988;138:768-70
26. Holick MF. Vitamin D and the skin photobiology, physiology and therapeutic efficacy for psoriasis. In: Heersche JNM, Kannais A, eds. Bone and Mineral Research, Vol 7. Amsterdam: Elsevier, 1990:313-66
27. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D synthesis in human skin. J Clin Edocrinol Metab 1988;67:373-8
28. Sita-Lumsden A, Swaminathan R, Milburn HJ. Sun related vitamin D deficiency and reactivation of tuberculosis. Thorax 2003;58:iii55
29. Sita-Lumsden A, Lapthorn G, Weekes E, Milburn HJ. Diet related vitamin D deficiency and reactivation of tuberculosis. Eur Respir J 2004;24(suppl 48): 416S
30. Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms among Gujerati Asians in west London: a case-control study. Lancet 2000;355:618-21
31. Singh SP, Mehra NK, Dinley HB, Pande JN, Vaidya MC. Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. J Infect Dis 1983;148:676-81
32. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NPAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998;338:640-4
33. Vidal SM, Malo D, Vogan K, Skamene E, Gross P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993;73:469-85
34. Hoal EG, Lewis L-A, Jamieson SE, et al. SLC11A1 (NRAMP1) but not SLC11A2 (NRAMP2) polymorphisms are associated with susceptibility to tuberculosis in a high-incidence community in South Africa. Int J Tuberc Lung Dis 2004;12:1464-71
35. Milburn HJ. Primary tuberculosis. Curr Opin Pulm Med 2001;7:133-41
36. Brandli O. The clinical presentation of tuberculosis. Respiration 1998;65:97-105
37. Cormican L, Hammal R, Messenger J, Milburn HJ. Current difficulties in the diagnosis and management of spinal tuberculosis. Postgrad Med J 2006;82:46-51
38. Piersimoni C, Scarparo C, Callegaro A, et al. Comparison of MB/Bact alert 3D system with radiometric BACTEC system and Lowenstein-Jensen medium for recovery and identification of mycobacteria from clinical specimens: a multicentre study. J Clin Microbiol 2001;39:651-7
39. Harvell JD, Hadley WK, Ng VL. Increased sensitivity of the BACTEC 460 mycobacterial radiometric broth culture system does not decrease the number of respiratory specimens required for a definitive diagnosis of pulmonary tuberculosis. J Clin Microbiol 2000;38:3608-11
40. Pai M, Riley LW, Colford JM Jr. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Inf Dis 2004;4:761-76
41. Roach RR, Bean AGD, Demangel C, France MP, Briscoe H, Britton WJ. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and cell clearance of mycobacterial infection. J Immunol 2002;168:4620-7
42. Keane J, Gershon SK, Braun MM. Tuberculosis and treatment with infliximab. N Engl J Med 2002;346:625-6
43. Manadan AM, Mohan AK, Cote TR, Siegal JN, Seqieira W, Block JA. Tuberculosis and etanercept. Proceedings of American College of Rheumatology Conference Atlanta, GA: ACR, 2002: abstract 356
44. Abbott Laboratories. Package literature for HUMIRA, July 2004. http www.humira.com (accessed June 2005)
45. Ormerod LP, Milburn HJ, Gillespie SH, Ledingham J, Rampton DS. For the British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in adult patients due to start anti-TNF-alpha treatment. Compiled on behalf of the Joint Tuberculosis Committee of the British Thoracic Society. Thorax 2005;60:800-5